BBC report on Alzheimer’s drug donanemab seen as turning point in fight against dementia

A breakthrough in the fight against Alzheimer’s disease. The BBC reported that a new drug is seen as a turning point in the battle against Alzheimer’s disease, as the worldwide trial confirmed that the new drug slows cognitive decline. What is the name of the drug that slows cognitive decline in the fight against Alzheimer’s? The drug that has suddenly become the hope of light in the dark is called “Donanemab”. Donanemab is the name of the new drug that is being hailed as a game changer. If you search the internet for what Donanemab is and how it treats Alzheimer’s disease, the following sections of this article will help you find out. Just stay with this page and review it till the end. Scroll down the page and take a look below.

Image Credit: BBC

BBC report on Alzheimer’s drug

Reports have suggested that the antibodies developed by Donanemab help in the early stages of Alzheimer’s disease, by removing a protein that accumulates in the brains of people with this type of dementia. Although Donanemab is not a cure for Alzheimer’s disease. According to the charities, the Journal JAMA results mark a new era in which disease can be cured. However, the UK drug watchdog has begun evaluating it for possible use on the NHS. This drug, Donanemab, reportedly only works on Alzheimer’s disease, not other types of dementia. Among other types of dementia, one is vascular dementia. Scroll down the page and read more details.

BBC Alzheimer's DrugImage Credit: BBC

Results from global trials suggested that the new drug Donanemab appears to slow the rate of disease by a third and allows people to maintain more tasks and activities of daily living, such as preparing food and pursuing hobbies. An 80-year-old man from the UK named Mike Colley, who is one of a few dozen patients, participated in the global trial. Recently, he spoke to the BBC. He continues reading this article and finds out what Mike Colley said.

See also  61 'Anarchists' Charged By Georgia AG for Attacking Atlanta 'Cop City' Training Facility

BBC Alzheimer's DrugImage Credit: BBC

Mike thinks he’s one of the luckiest people you’ll ever meet, receiving an infusion every month at a London hospital. Mike had memory problems and was unable to make decisions right before the trial began. Mike’s son Mark said: “Watching him struggle with information processing and problem solving was very difficult. But I think the decline is reaching a plateau now.” Now Mike feels more secure every day.

Categories: Trending

Leave a Comment